Watkins NA - Search Results

1

Systematic Mendelian randomization using the human plasma proteome to discover potential therapeutic targets for stroke.

Chen L, Peters JE, Prins B, Persyn E, Traylor M, Surendran P, Karthikeyan S, Yonova-Doing E, Di Angelantonio E, Roberts DJ, Watkins NA, Ouwehand WH, Danesh J, Lewis CM, Bronson PG, Markus HS, Burgess S, Butterworth AS, Howson JMM. Chen L, et al. Among authors: watkins na. Nat Commun. 2022 Oct 17;13(1):6143. doi: 10.1038/s41467-022-33675-1. Nat Commun. 2022. PMID: 36253349 Free PMC article.

2

Novel diagnostic and therapeutic strategies with genetically engineered human antibodies.

Ouwehand WH, Watkins N. Ouwehand WH, et al. Vox Sang. 1998;74 Suppl 2:223-32. doi: 10.1111/j.1423-0410.1998.tb05424.x. Vox Sang. 1998. PMID: 9704449 Review.

3

Rapid phenotyping of HPA-1a using either diabody-based hemagglutination or recombinant IgG1-based assays.

Watkins NA, Armour KL, Smethurst PA, Metcalfe P, Scott ML, Hughes DL, Smith GA, Williamson LM, Clark MR, Ouwehand WH. Watkins NA, et al. Transfusion. 1999 Jul;39(7):781-9. doi: 10.1046/j.1537-2995.1999.39070781.x. Transfusion. 1999. PMID: 10413288

4

Introduction to antibody engineering and phage display.

Watkins NA, Ouwehand WH. Watkins NA, et al. Vox Sang. 2000;78(2):72-9. doi: 10.1159/000031154. Vox Sang. 2000. PMID: 10765141 Review.

5

The isolation and characterisation of human monoclonal HLA-A2 antibodies from an immune V gene phage display library.

Watkins NA, Brown C, Hurd C, Navarrete C, Ouwehand WH. Watkins NA, et al. Tissue Antigens. 2000 Mar;55(3):219-28. doi: 10.1034/j.1399-0039.2000.550305.x. Tissue Antigens. 2000. PMID: 10777097

6

Platelet alphaIIbbeta3 recombinant autoantibodies from the B-cell repertoire of a post-transfusion purpura patient.

Watkins NA, Smethurst PA, Allen D, Smith GA, Ouwehand WH. Watkins NA, et al. Br J Haematol. 2002 Mar;116(3):677-85. doi: 10.1046/j.0007-1048.2001.03301.x. Br J Haematol. 2002. PMID: 11849233 Free article.

7

HPA-1a phenotype-genotype discrepancy reveals a naturally occurring Arg93Gln substitution in the platelet beta 3 integrin that disrupts the HPA-1a epitope.

Watkins NA, Schaffner-Reckinger E, Allen DL, Howkins GJ, Brons NH, Smith GA, Metcalfe P, Murphy MF, Kieffer N, Ouwehand WH. Watkins NA, et al. Blood. 2002 Mar 1;99(5):1833-9. doi: 10.1182/blood.v99.5.1833. Blood. 2002. PMID: 11861302 Free article.

8

The low-frequency allele of the platelet collagen signaling receptor glycoprotein VI is associated with reduced functional responses and expression.

Joutsi-Korhonen L, Smethurst PA, Rankin A, Gray E, IJsseldijk M, Onley CM, Watkins NA, Williamson LM, Goodall AH, de Groot PG, Farndale RW, Ouwehand WH. Joutsi-Korhonen L, et al. Among authors: watkins na. Blood. 2003 Jun 1;101(11):4372-9. doi: 10.1182/blood-2002-08-2591. Epub 2003 Jan 30. Blood. 2003. PMID: 12560230 Free article.

9

The effect of recombinant IgG antibodies against the leucine-33 form of the platelet beta3 integrin (HPA-1a) on platelet function.

Joutsi-Korhonen L, Preston S, Smethurst PA, Ijsseldijk M, Schaffner-Reckinger E, Armour KL, Watkins NA, Clark MR, de Groot PG, Farndale RW, Ouwehand WH, Williamson LM. Joutsi-Korhonen L, et al. Among authors: watkins na. Thromb Haemost. 2004 Apr;91(4):743-54. doi: 10.1160/TH03-07-0484. Thromb Haemost. 2004. PMID: 15045136

10

Monoclonal antibody therapies in transfusion medicine.

Ouwehand WH, Watkins NA, Garner SF, Smethurst PA. Ouwehand WH, et al. Among authors: watkins na. Vox Sang. 2004 Jul;87 Suppl 2:151-4. doi: 10.1111/j.1741-6892.2004.00490.x. Vox Sang. 2004. PMID: 15209903 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

131 results

Search Page